Autophagy-mediated NKG2D internalization impairs NK cell function and exacerbates radiation pneumonitis

IntroductionRadiation pneumonitis is a critical complication that constrains the use of radiation therapy for thoracic malignancies, leading to substantial morbidity via respiratory distress and lung function impairment. The role of Natural killer (NK) cells in inflammatory diseases is well-document...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Ruiqing Wang, Xinyue Ma, Xinyu Zhang, Dizhi Jiang, Hongyuan Mao, Zerun Li, Yu Tian, Bo Cheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Subjects:	radiation pneumonitis CXCL10/CXCR3 autophagy NKG2D NK cell
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1250920/full

Similar Items

Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10
by: Min He, et al.
Published: (2024-12-01)

Exploring the dynamic of NKG2D/NKG2DL axis: A central regulator of NK cell functions
by: Caterina Marangio, et al.
Published: (2025-05-01)

IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10
by: Xin Fang, et al.
Published: (2022-03-01)

Increased proliferative response of highly differentiated CD57<sup>+</sup>NKG2C<sup>+</sup>NK cells expressing NKG2A
by: N. A. Alekseeva, et al.
Published: (2024-09-01)

Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
by: Peggy Riese, et al.
Published: (2020-06-01)

Blocking NKG2A in Echinococcus multilocularis infection partially relieves impairment of NK cell function of the host
by: Ayinuer Aierken, et al.
Published: (2025-08-01)

POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01)

Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins
by: Miriam Aarsund, et al.
Published: (2022-09-01)

NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01)

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
by: Ignacio Melero, et al.
Published: (2023-10-01)

The role of CXCR3 and its ligands in cancer
by: Xiaoming Wang, et al.
Published: (2022-11-01)

Co-expression of IL-21-Enhanced NKG2D CAR-NK cell therapy for lung cancer
by: Yan Zhang, et al.
Published: (2024-01-01)

Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
by: Jagoda Siemaszko, et al.
Published: (2023-10-01)

Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells
by: Haeryung Cho, et al.
Published: (2021-06-01)

Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
by: Ma Jingfeng, et al.
Published: (2025-06-01)

Hepatic alveolar echinococcosis infection induces a decrease in NK cell function through high expression of NKG2A in patients
by: Abuduaini Abulizi, et al.
Published: (2025-05-01)

NKG2D and Its Ligands: “One for All, All for One”
by: Alessandra Zingoni, et al.
Published: (2018-03-01)

Correction: Hepatic alveolar echinococcosis infection induces a decrease in NK cell function through high expression of NKG2A in patients
by: Abuduaini Abulizi, et al.
Published: (2025-10-01)

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
by: Tobias Zöller, et al.
Published: (2018-03-01)

Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness
by: Vanna Imširović, et al.
Published: (2023-07-01)

INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
by: E. V. Abakushina, et al.
Published: (2017-01-01)

Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
by: Mariya Lazarova, et al.
Published: (2019-11-01)

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01)

Two major human phenotypes of MICA molecules and their differential activation to NK cells via NKG2D receptor
by: Qizhi Luo, et al.
Published: (2025-05-01)

Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar)
by: Natalia Valdés, et al.
Published: (2024-09-01)

Designs of NKG2D-based immunotherapeutics for cancer
by: Jianfeng Han, et al.
Published: (2025-06-01)

Leveraging NKG2D Ligands in Immuno-Oncology
by: Mercedes Beatriz Fuertes, et al.
Published: (2021-07-01)

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
by: Daciana C. Dumut, et al.
Published: (2025-02-01)

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
by: Jack G. Fisher, et al.
Published: (2022-11-01)

Hepatitis D virus infection triggers CXCL9-11 upregulation in hepatocytes and liver infiltration of CXCR3+ CD4 T cells
by: Jan-Hendrik Bockmann, et al.
Published: (2025-03-01)

PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop
by: Noor Abdala-Saleh, et al.
Published: (2024-10-01)

Molecular bases for the regulation of NKG2D ligands in cancer
by: Leticia eHuergo-Zapico, et al.
Published: (2014-03-01)

NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
by: Alessandra Zingoni, et al.
Published: (2020-03-01)

A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
by: Trever T Greene, et al.
Published: (2016-11-01)

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
by: Tobias Bexte, et al.
Published: (2022-12-01)

Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients
by: Sergi Pascual-Guardia, et al.
Published: (2020-03-01)

The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
by: Nathan Reynders, et al.
Published: (2019-06-01)

Highlighting a New Potential Target in Stroke: Immunoreceptor NKG2D
by: Josef Anrather, et al.
Published: (2023-06-01)

Expression features of CD16 and NKG2D receptors by NK cells, NKT cells and T lymphocytes of peripheral blood associated with female infertility
by: V. A. Mikhailova, et al.
Published: (2025-07-01)

Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
by: Adeline Raynaud, et al.
Published: (2021-01-01)